admin A new R01 grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) was awarded to Dr. Lieselot Carrette, with Dr. Abraham Palmer as co-investigator.
The 4-year grant is titled “Magnetic Resonance Imaging of Outbred Rats with Variable Vulnerability to Compulsive Alcohol Use” and it will start September 20, 2025 and end on August 31, 2029.
Congratulations!
Dr. Abraham Palmer gave a talk titled “Genetic evidence supports a relationship between locomotor activity in a novel environment in rodents a human externalizing behavior” at the National Institute on Drug Abuse (NIDA) annual team meeting for Genetics and Epigenetics Cross-Cutting Research on September 11, 2025 at the National Institutes of Health campus in Bethesda, MD.
His talk was during the session titled “Harnessing Model Organism Genetics and Genomics in the Understanding the Role of Human Genetic Variation in SUDs,” which he co-chaired with Dr. Elissa Chesler.
(Pictured left to right:)
Xia Yang, Danielle Dick, Abraham Palmer, Elissa Chesler, and Marianne Seney
The manuscript titled “A Preclinical Alcohol Biobank: Samples from Behaviorally Characterized HS Rats for AUD Research” was accepted in eNeuro.
Authors: Michelle Doyle, Paola Campo, Selen Dirik, Maria Balaguer, Angelica Martinez, Marsida Kallupi, Abraham Palmer, and Giordano de Guglielmo
Congratulations!
A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Pejman Mohammadi and Dr. Abraham Palmer.
The grant is titled “Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats” (U01DA060443) and it will start July 1, 2025 and end on March 31, 2030.
A new R21 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Marsida Kallupi, with Dr. Abraham Palmer as co-investigator.
The 2-year grant is titled “Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of RATTACA Rats” and it will start July 15, 2025 and end on June 30, 2027.
Congratulations!